Dr. Anela Vukoja
Anela helps shape R&D strategy and clinical development plans of our portfolio companies by designing and implementing data-driven processes. She moreover helps grow our portfolio by identifying new investment opportunities and supports company creation with the ultimate goal of prolonging the human healthspan via pharmaceutical interventions.
Prior to joining Apollo, Anela was a manager at a boutique consultancy firm Catenion, specializing in R&D strategy and serving international biotech and pharma companies as well as top tier VCs and hedge funds. Anela holds a PhD in neurobiology from the Free University of Berlin as well as bachelor's and master's degrees in molecular biology.